Avadel Pharmaceuticals to Present at the Ladenburg Thalmann Annual Healthcare Conference 2021

Rhea-AI Summary

Avadel Pharmaceuticals plc (Nasdaq: AVDL) announced that its CEO, Greg Divis, will participate in a fireside chat on July 14 at 11:00 a.m. ET. The discussion will focus on FT218, an investigational treatment for excessive daytime sleepiness and cataplexy in adults with narcolepsy. A live webcast will be available on Avadel’s Investor Relations website, along with an archived recording accessible for 90 days after the event. This engagement highlights Avadel's commitment to advancing its innovative therapies.

DUBLIN, Ireland, July 07, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating excessive daytime sleepiness and cataplexy in adults with narcolepsy, announced today that Greg Divis, Chief Executive Officer of Avadel, will participate in a fireside chat on Wednesday, July 14 at 11:00 a.m. ET.

A live webcast of this event, as well as an archived recording, will be available on Avadel’s Investor Relations website, www.investors.avadel.com, for 90 days following the conference.

About Avadel Pharmaceuticals plc
Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company primarily focused on the development and FDA approval of FT218, an investigational, once-nightly, extended-release formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy. For more information, please visit www.avadel.com.

Investor Contact:
Courtney Turiano
Stern Investor Relations, Inc.
Courtney.Turiano@sternir.com
(212) 698-8687

Media Contact:
Nicole Raisch Goelz
Real Chemistry
ngoelz@realchemistry.com
(408) 568-4292

 

FAQ

What is the date and time of the Avadel Pharmaceuticals fireside chat?

The fireside chat will take place on July 14 at 11:00 a.m. ET.

Who is participating in the fireside chat for Avadel Pharmaceuticals?

Greg Divis, the CEO of Avadel Pharmaceuticals, will participate in the fireside chat.

What is FT218 and what condition does it aim to treat?

FT218 is an investigational, once-nightly formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy.

Where can I watch the Avadel Pharmaceuticals fireside chat?

The fireside chat will be available for live streaming on Avadel’s Investor Relations website.

How long will the recorded session of the fireside chat be available?

The archived recording of the fireside chat will be accessible for 90 days after the event.